Close Menu

NEW YORK (GenomeWeb) – Precision Therapeutics announced today that it has signed a definitive agreement to merge with Helomics.

Under the terms of the deal, Precision — formerly Skyline Medical — will acquire the 75 percent of Helmomics' shares it does not currently own, having already taken a 25 percent equity stake in the firm in December.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.